Aligos Therapeutics (NASDAQ:ALGS) just reported results for the first quarter of 2024.
- Aligos Therapeutics reported earnings per share of -22 cents. This was below the analyst estimate for EPS of -19 cents.
- The company reported revenue of $986,000.
Source: iQoncept / Shutterstock
Aligos Therapeutics (NASDAQ:ALGS) just reported results for the first quarter of 2024.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/algs-stock-earnings-aligos-therapeutics-for-q1-of-2024/.
©2025 InvestorPlace Media, LLC